title: Relationship between Rgs2 gene expression level and anxiety and depression-like behaviour in a mutant mouse model: serotonergic involvement.
abstract: RGS2 is a member of a family of proteins that negatively modulate G-protein coupled receptor transmission. Variations in the RGS2 gene were found to be associated in humans with anxious and depressive phenotypes. We sought to study the relationship of Rgs2 expression level to depression and anxiety-like behavioural features, sociability and brain 5-HT1A and 5-HT1B receptor expression. We studied male mice carrying a mutation that causes lower Rgs2 gene expression, employing mice heterozygous (Het) or homozygous (Hom) for this mutation, or wild-type (WT). Mice were subjected to behavioural tests reflecting depressive-like behaviour [forced swim test (FST), novelty suppressed feeding test (NSFT)], elevated plus maze (EPM) for evaluation of anxiety levels and the three-chamber sociability test. The possible involvement of raphe nucleus 5-HT1A receptors in these behavioural features was examined by 8-OH-DPAT-induced hypothermia. Expression levels of 5-HT1A and 5-HT1B receptors in the cortex, raphe nucleus and hypothalamus were compared among mice of the different Rgs2 genotype groups. NSFT results demonstrated that Hom mice showed more depressive-like features than Rgs2 Het and WT mice. A trend for such a relationship was also suggested by the FST results. EPM and sociability test results showed Hom and Het mice to be more anxious and less sociable than WT mice. In addition Hom and Het mice were characterized by lower basal body temperature and demonstrated less 8-OH-DPAT-induced hypothermia than WT mice. Finally, Hom and Het mice had significantly lower 5-HT1A and 5-HT1B receptor expression levels in the raphe than WT mice. Our findings demonstrate a relationship between Rgs2 gene expression level and a propensity for anxious and depressive-like behaviour and reduced social interaction that may involve changes in serotonergic receptor expression.
authors: Department of Psychiatry, Biological Psychiatry Laboratory, Hadassah-Hebrew University Medical Center, Ein Kerem, Jerusalem, Israel.
authors: Tzuri
authors: T
authors: Lifschytz
authors: Esther Channah
authors: EC
authors: Broner
authors: Polina
authors: P
authors: Zozulinsky
authors: Alexandra
authors: A
authors: Slonimsky
authors: Renana
authors: R
authors: Eitan
authors: Lior
authors: L
authors: Greenbaum
authors: Bernard
authors: B
authors: Lerer
mesh_terms: D017371:8-Hydroxy-2-(di-n-propylamino)tetralin / Q000494:pharmacology; D000704:Analysis of Variance; D000818:Animals; D001007:Anxiety / Q000235:genetics* / Q000523:psychology*; D001923:Brain Chemistry / Q000235:genetics; D003863:Depression / Q000235:genetics* / Q000523:psychology*; D005247:Feeding Behavior / Q000187:drug effects; D005260:Female; D015870:Gene Expression / Q000502:physiology*; D005838:Genotype; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009154:Mutation / Q000235:genetics / Q000502:physiology; D020710:RGS Proteins / Q000235:genetics*; D060888:Real-Time Polymerase Chain Reaction; D012701:Serotonin / Q000502:physiology*; D017366:Serotonin Receptor Agonists / Q000494:pharmacology; D012919:Social Behavior; D012931:Social Environment; D013550:Swimming / Q000523:psychology
chemical_list: D020710:RGS Proteins; C105345:Rgs2 protein, mouse; D017366:Serotonin Receptor Agonists; D012701:Serotonin; D017371:8-Hydroxy-2-(di-n-propylamino)tetralin